THANK YOU FOR SUBSCRIBING
Medical Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
Bone Health Advisory appoints Dr. Karpf and Dr. Rosen to help clinicians and patients cure and prevent Osteoporosis.
FREMONT, CA: Bone Health Technologies announces the appointment of two additional members to its Scientific Advisory Board - David B. Karpf, MD (Stanford) and Harold Rosen, MD (Harvard).
Dr. David Karpf is a Clinical Professor of Endocrinology, Gerontology & Metabolism at Stanford University School of Medicine, and Attending, Osteoporosis & Metabolic Bone Disease Clinic at Stanford University Hospital & Clinics. Also, he is the Co-Chair of the Medical & Scientific Advisory Board for American Bone Health and a Fellow of the ASBMR. Dr. Karpf is a UC Berkeley graduate who received his medical degree from UC San Diego and completed a residency in internal medicine and fellowship in endocrinology, diabetes, and metabolism at UCLA/Cedars-Sinai Medical Center, followed by a fellowship in metabolic bone disease in the endocrine bone unit at UCSF, where his bench research focused on the characterization and isolation of the PTH/PTHrP receptor. He is a well known expert and researcher in the field of Osteoporosis and led the landmark Fosamax® Fracture Intervention Trial and the pivotal trials that resulted in the approval of Boniva and several other trials for Osteoporosis therapeutic interventions.
Dr. Harold Rosen is an Associate Professor of Medicine at Harvard and did fellowships in Endocrinology and Geriatrics at Beth Israel Hospital in Boston. He has spent years doing clinical research in osteoporosis. He investigated the relationship between vitamin K and bone, thyroid hormone-induced bone loss, and the role of biochemical markers of bone turnover. In 1998 he became the Director of the Osteoporosis Prevention and Treatment Center at Beth Israel Deaconess Medical Center in Boston. In this capacity, he runs bone densitometry, sees patients in consultation for osteoporosis and metabolic bone disease, and performs research on optimizing performance and reporting of bone densitometry. He has been active in his professional society, the ISCD (International Society for Clinical Densitometry), where he served on the Board of Directors from 2010-2013. Dr. Rosen has received the ISCD Clinician of the year Award in 2010 and the Paul Miller award for service to the ISCD in 2017.
“As we develop the OsteoBoost belt and digital health platform we aim to apply the most rigorous clinical standards of evidence to our research and development and then work effectively with clinicians and patients to help them treat and prevent this serious disease - the opportunity to work with thought-leading clinicians such as Dr. Karpf and Rosen, is of tremendous importance in this process. We are so thrilled to have them involved with our work.” said Laura Yecies, CEO and Board Member of Bone Health Technologies.
Read Also
